Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
How it described itself
Our first challenge is potassium (K+)
Continuous, real-time, and accurate biomarker monitoring to better manage chronic disease and save lives.
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
Seen November 2026 · 1 capture · latest observed messagingA new era of potassium intelligence
Proton Intelligence is developing CKM™, an investigational continuous potassium monitoring platform for heart failure and kidney disease care.